Dr. Fabrizio Carta received his degree in 2002 in Pharmaceutical Chemistry and Technology from the University of Sassari (IT). In 2008, he received his Ph.D. in Chemistry at the School of Chemistry from the Bristol University (UK). He was appointed as a postdoctoral fellow at MIT (USA) and finally, joined Prof. Scozzafava’s and Supuran’s groups at the University of Florence (IT). Among others, he is an Editorial Board Member of the Journal of Enzyme Inhibition and Medicinal Chemistry (JEIMC) and the Journal of the Turkish Chemical Society, Section A: Chemistry (JOTCSA). He is co-author of > 300 publications on peer-reviewed international journals, 15 book chapters, and 5 WO patents.
Dr. Fabrizio Carta received his degree in 2002 in Pharmaceutical Chemistry and Technology from the University of Sassari (IT). In 2008, he received his Ph.D. in Chemistry at the School of Chemistry from the Bristol University (UK). He was appointed as a postdoctoral fellow at MIT (USA) and finally, joined Prof. Scozzafava’s and Supuran’s groups at the University of Florence (IT). Among others, he is an Editorial Board Member of the Journal of Enzyme Inhibition and Medicinal Chemistry (JEIMC) and the Journal of the Turkish Chemical Society, Section A: Chemistry (JOTCSA). He is co-author of > 300 publications on peer-reviewed international journals, 15 book chapters, and 5 WO patents.